Human immunodeficiency virus 1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1

Journal of General Virology

Volumn 85, Issue 7, 2004, Pages 1945-1954

  Derrien, Muriel ^a   Pizzato, Nathalie ^b   Dolcini, Guillermina ^a   Menu, Elisabeth ^a,b   Chaouat, Gérard ^b   Lenfant, Françoise ^b   Barré Sinoussi, Françoise ^a   Le Bouteiller, Philippe ^b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE ANTIGEN; NEF PROTEIN; PLASMID DNA; VPU PROTEIN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA-G ANTIGEN; IMMUNOGLOBULIN CLASS;

ANTIGEN EXPRESSION; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE CONSTRUCT; GENE DELETION; GENETIC CODE; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; VIRUS IMMUNITY; VIRUS PATHOGENESIS; ANTIBODY SPECIFICITY; CELL LINE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIBODY SPECIFICITY; CELL LINE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HLA ANTIGENS; HLA-A2 ANTIGEN; HUMANS; IMMUNOGLOBULIN ISOTYPES;

EID: 3343019387     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.79867-0     Document Type: Article

References (41)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A. & Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59, 284-291.
2. Besnard-Guérin, C., Belaïdouni, N., Lassot, I., Segaral, E., Jobart, A., Marchal, C. & Benarous, R. (2004). HIV-1 Vpu sequesters β-transducin repeat-containing protein (βTrCP) in the cytoplasm and provokes the accumulation of β-catenin and other SCFβTrCP substrates. J Biol Chem 279, 788-795.
3. Blagoveshchenskaya, A. D., Thomas, L., Feliciangeli, S. F., Hung, C. H. & Thomas, G. (2002). HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111, 853-866.
4. Bour, S., Schubert, U. & Strebel, K. (1995). The human immunodeficiency virus type 1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J Virol 69, 1510-1520.
5. Bour, S., Perrin, C., Akari, H. & Strebel, K. (2001). The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of IkappaB. J Biol Chem 276, 15920-15928.
6. Buonocore, L., Turi, T. G., Crise, B. & Rose, J. K. (1994). Stimulation of heterologous protein degradation by the Vpu protein of HIV-1 requires the transmembrane and cytoplasmic domains of CD4. Virology 204, 482-486.
7. Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L. & Baltimore, D. (1999). The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661-671.
8. Collins, K. L. & Baltimore, D. (1999). HIV's evasion of the cellular immune response. Immunol Rev 168, 65-74.
9. Corbeau, P., Benkirane, M., Weil, R., David, C., Emiliani, S., Olive, D., Mawas, C., Serre, A. & Devaux, C. (1993). Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry. J Immunol 150, 290-301.
10. Deng, H., Unutmaz, D., KewalRamani, V. N. & Littman, D. R. (1997). Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296-300.
11. Fisher, S., Genbacev, O., Maidji, E. & Pereira, L. (2000). Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 74, 6808-6820.
12. + cells by interacting with CD8. J Immunol 164, 6100-6104.
13. Geraghty, D. E., Koller, B. H. & Orr, H. T. (1987). A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc Natl Acad Sci U S A 84, 9145-9149.
14. Gromme, M. & Neefjes, J. (2002). Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways. Mol Immunol 39, 181-202.
15. Halary, F., Amara, A., Lortat-Jacob, H. & 7 other authors (2002). Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 17, 653-664.
16. Ishitani, A. & Geraghty, D. E. (1992). Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 88, 3947-3951.
17. Ishitani, A., Sageshima, N., Lee, N., Dorofeeva, N., Hatake, K., Marquardt, H. & Geraghty, D. E. (2003). Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 171, 1376-1384.
18. Kerkau, T., Bacik, I., Bennink, J. R., Yewdell, J. W., Hunig, T., Schimpl, A. & Schubert, U. (1997). The human immunodeficiency virus type 1 (HIV- 1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J Exp Med 185, 1295-1305.
19. Kikkert, M., Hassink, G., Barel, M., Hirsch, C., Van Der Wal, F. J. & Wiertz, E. (2001). Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. Biochem J 358, 369-377.
20. Klimkait, T., Strebel, K., Hoggan, M. D., Martin, M. A. & Orenstein, J. M. (1990). The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release. J Virol 64, 621-629.
21. Le Bouteiller, P. & Blaschitz, A. (1999). The functionality of HLA-G is emerging. Immunol Rev 167, 233-244.
22. Lee, N., Malacko, A. R., Ishitani, A., Chen, M. C., Bajorath, J., Marquardt, H. & Geraghty, D. E. (1995). The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3, 591-600.
23. Lefebvre, S., Antoine, M., Uzan, S., McMaster, M., Dausset, J., Carosella, E. D. & Paul, P. (2002). Specific activation of the nonclassical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 196, 266-274.
24. Lemonnier, F. A., Le Bouteiller, P., Olive, D. & 7 other authors (1984). Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody. J Immunol 132, 1176-1182.
25. Lenburg, M. E. & Landau, N. R. (1993). Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J Virol 67, 7238-7245.
26. Lenfant, F., Pizzato, N., Liang, S., Davrinche, C., Le Bouteiller, P. & Horuzsko, A. (2003). Induction of HLA-G-restricted human cytomegalovirus pp65 (UL83)-specific cytotoxic T lymphocytes in HLA-G transgenic mice. J Gen Virol 84, 307-317.
27. + T cell regulatory mechanism. Proc Natl Acad Sci U S A 98, 12150-12155.
28. Lopez-Botet, M., Llano, M., Navarro, F. & Bellon, T. (2000). NK cell recognition of non-classical HLA class I molecules. Semin Immunol 12, 109-119.
29. Lozano, J. M., Gonzalez, R., Kindelan, J. M., Rouas-Freiss, N., Caballos, R., Dausset, J., Carosella, E. D. & Pena, J. (2002). Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16, 347-351.
30. Onno, M., Pangault, C., Le Friec, G., Guilloux, V., Andre, P. & Fauchet, R. (2000). Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164, 6426-6434.
31. Park, B., Lee, S., Kim, E., Chang, S., Jin, M. & Ahn, K. (2001). The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments. Immunity 15, 213-224.
32. Perez-Bercoff, D., David, A., Sudry, H., Barré-Sinoussi, F. & Pancino, G. (2003). Fcγ receptor-mediated suppression of HIV replication in primary human macrophages. J Virol 77, 4081-4094.
33. Schust, D. J., Tortorella, D. & Ploegh, H. L. (1999). HLA-G and HLA-C at the feto-maternal interface: lessons learned from pathogenic viruses. Semin Cancer Biol 9, 37-46.
34. Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. M. (1996). Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 2, 338-342.
35. Solier, C., Aguerre-Girr, M., Lenfant, F., Campan, A., Berrebi, A., Rebmann, V., Grosse-Wilde, H. & Le Bouteiller, P. (2002 . Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast. Eur J Immunol 32, 3576-3586.
36. Spencer, J. V., Lockridge, K. M., Barry, P. A., Lin, G., Tsang, M., Penfold, M. E. & Schall, T. J. (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J Virol 76, 1285-1292.
37. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. & Ploegh, H. L. (2000). Viral subversion of the immune system. Annu Rev Immunol 18, 861-926.
38. Vincent, M. J., Raja, N. U. & Jabbar, M. A. (1993). Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J Virol 67, 5538-5549.
39. Wiendl, H., Mitsdoerffer, M., Hofmeister, V., Wischhusen, J., Bornemann, A., Meyermann, R., Weiss, E. H., Melms, A. & Weller, M. A. (2002). Functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 168, 4772-4780.
40. Williams, M., Roeth, J. F., Kasper, M. R., Fleis, R. I., Przybycin, C. G. & Collins, K. L. (2002). Direct binding of human immunodeficiency virus type 1 Nef to the major histocompatibility complex class I (MHC-I) cytoplasmic tail disrupts MHC-I trafficking. J Virol 76, 12173-12184.
41. Yang, Y., Chu, W., Geraghty, D. E. & Hunt, J. S. (1996). Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma. J Immunol 156, 4224-4231.